Foreword

Venous thromboembolism is the third leading cause of vascular disease (after myocardial infarction and cerebral vascular accidents), which can affect up to approximately 600,000 Americans annually, according to the American Heart Association. The increasing use of direct oral anticoagulants (DOAC) has given the clinician several options for prophylaxis and treatment over the past decade.
Source: Disease a Month - Category: Infectious Diseases Authors: Source Type: research